Halozyme Therapeutics (HALO) Free Cash Flow (2010 - 2026)
Halozyme Therapeutics (HALO) posted Free Cash Flow of $236.72 million for Q2 2026, up 141.2% from $98.15 million a year earlier and up 34.2% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Free Cash Flow (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Free Cash Flow at Halozyme Therapeutics was $806.22 million, up 49.1% year-over-year; for FY2025, it was $644.59 million, up 37.6% from FY2024.
- Annual Free Cash Flow has increased for three consecutive years, with a five-year compound annual growth rate of 64.8% (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' Free Cash Flow was $468.37 million in FY2024 (+25.5%), $373.28 million in FY2023 (+58.6%), $235.3 million in FY2022 (-21.0%) and $297.98 million in FY2021 (+462.8%).
- The Q2 2026 figure stands as the highest quarterly Free Cash Flow in data going back to Q3 2010.
- On a year-over-year basis, Free Cash Flow has increased in each of the last seven quarters, with growth averaging 50.6% over the last eight quarters.
- The strongest year-over-year quarter for Free Cash Flow in the past five years was Q2 2026, with growth of 141.2%; the weakest was Q3 2022, with a decline of 43.4%.
- According to Business Quant data, Free Cash Flow for the three prior quarters was $176.34 million (Q1 2026), $217.6 million (Q4 2025) and $175.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.76 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 7.30 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.11 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 4.48 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 6.20 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 5.34 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.43 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Halozyme Therapeutics | 12.20 Bn | 10.80 Bn | 401.83 Mn | 236.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 236.72 Mn |
| Mar 31, 2026 | 176.34 Mn |
| Dec 31, 2025 | 217.60 Mn |
| Sep 30, 2025 | 175.57 Mn |
| Jun 30, 2025 | 98.15 Mn |
| Mar 31, 2025 | 153.27 Mn |
| Dec 31, 2024 | 175.42 Mn |
| Sep 30, 2024 | 113.86 Mn |
| Jun 30, 2024 | 53.21 Mn |
| Mar 31, 2024 | 125.88 Mn |
| Dec 31, 2023 | 99.76 Mn |
| Sep 30, 2023 | 129.47 Mn |
| Jun 30, 2023 | 68.47 Mn |
| Mar 31, 2023 | 75.59 Mn |
| Dec 31, 2022 | 80.11 Mn |
| Sep 30, 2022 | 68.63 Mn |
| Jun 30, 2022 | 39.26 Mn |
| Mar 31, 2022 | 47.31 Mn |
| Dec 31, 2021 | 82.36 Mn |
| Sep 30, 2021 | 121.24 Mn |
API Access
Halozyme Therapeutics Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();